These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2399565)

  • 1. Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA.
    Gion M; Mione R; Gatti C; Dittadi R; Leon A; Nascimben O; Pizzorno B; Bruscagnin G
    Tumori; 1990 Aug; 76(4):360-4. PubMed ID: 2399565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases.
    Nicolini A; Tartarelli G; Carpi A; Metelli MR; Ferrari P; Anselmi L; Conte M; Berti P; Miccoli P
    BMC Cancer; 2006 Nov; 6():269. PubMed ID: 17116247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of serum CA15-3 determination with CEA and TPA in the post-operative follow-up of breast cancer patients.
    Nicolini A; Colombini C; Luciani L; Carpi A; Giuliani L
    Br J Cancer; 1991 Jul; 64(1):154-8. PubMed ID: 1854615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen, ferritin, tissue polypeptide antigen, and CA15/3 in breast cancer: relationship between carcinoma and normal breast tissue.
    Gion M; Mione R; Dittadi R; Griggio L; Munegato G; Valsecchi M; Del Maschio O; Bruscagnin G
    Int J Biol Markers; 1986; 1(1):33-8. PubMed ID: 3480322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissue.
    Gion M; Mione R; Barioli P; Sartorello P; Capitanio G
    Eur J Clin Chem Clin Biochem; 1994 Oct; 32(10):779-87. PubMed ID: 7865616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum CA549 in primary breast cancer: comparison with CA15.3 and MCA.
    Gion M; Plebani M; Mione R; Penzo C; Meo S; Burlina A
    Br J Cancer; 1994 Apr; 69(4):721-5. PubMed ID: 8142260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer.
    Steger GG; Mader R; Derfler K; Moser K; Dittrich C
    Klin Wochenschr; 1989 Aug; 67(16):813-7. PubMed ID: 2796251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA-15.3, TPA and MCA as markers for breast cancer.
    Barak M; Steiner M; Finkel B; Abrahamson J; Antal S; Gruener N
    Eur J Cancer; 1990; 26(5):577-80. PubMed ID: 2144745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mucinous-like carcinoma-associated antigen (MCA) in the tissue and blood of patients with primary breast cancer.
    Bombardieri E; Gion M; Mione R; Dittadi R; Bruscagnin G; Buraggi G
    Cancer; 1989 Feb; 63(3):490-5. PubMed ID: 2643453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple method for comparing reliability of two serum tumour markers in breast carcinoma.
    O'Brien DP; Gough DB; Skehill R; Grimes H; Given HF
    J Clin Pathol; 1994 Feb; 47(2):134-7. PubMed ID: 8132827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CEA, TPA and CA 15.3 in tissue and serum of breast cancer patients.
    Saccani Jotti G; Grassi C; Fontanesi M; Becchi G; Gion M
    Int J Biol Markers; 1992; 7(4):265-6. PubMed ID: 1491185
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.
    Pectasides D; Pavlidis N; Gogou L; Antoniou F; Nicolaides C; Tsikalakis D
    Am J Clin Oncol; 1996 Oct; 19(5):459-64. PubMed ID: 8823487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases.
    Gion M; Mione R; Nascimben O; Valsecchi M; Gatti C; Leon A; Bruscagnin G
    Br J Cancer; 1991 May; 63(5):809-13. PubMed ID: 2039707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of CA15.3, mucin-like carcinoma-associated antigen and carcinoembryonic antigen in determining the clinical course in patients with metastatic breast cancer.
    Deprés-Brummer P; Itzhaki M; Bakker PJ; Hoek FJ; Veenhof KH; de Wit R
    J Cancer Res Clin Oncol; 1995; 121(7):419-22. PubMed ID: 7635872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and tissue levels of CEA, TPA, CA 125 and CA 15.3 in patients with lung cancer.
    Macchia V; Paduano D; Di Carlo A; Mariano A; Cecere C; Ferrante G
    Int J Biol Markers; 1993; 8(4):215-20. PubMed ID: 8138661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of preoperative CA 15-3 levels in operable breast cancer. Comparison with tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
    Iaffaioli RV; Caponigro F; Esposito G; Pagliarulo C; Deplacido S; Ungaro B; Bazzicalupo L; Frasci G; Bianco AR
    Int J Biol Markers; 1991; 6(1):21-4. PubMed ID: 1856513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary report on the usefulness of monoclonal antibodies to CA 15-3 and MCA in the detection of micrometastases in axillary lymph nodes draining primary breast carcinoma.
    Byrne J; Horgan PG; England S; Callaghan J; Given HF
    Eur J Cancer; 1992; 28(2-3):658-60. PubMed ID: 1591088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan.
    Seregni E; Crippa F; Botti C; Bellotti MG; Bogni A; Pizzichetta M; Bombardieri E
    Int J Biol Markers; 1993; 8(2):124-9. PubMed ID: 8366295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCA in patients with breast cancer: correlation with CEA and CA15-3.
    Molina R; Filella X; Mengual P; Prats M; Zanon G; Daniels M; Ballesta AM
    Int J Biol Markers; 1990; 5(1):14-21. PubMed ID: 2230347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.